China To Issue New National Reimbursement List In November; MNC Margin Likely Lower
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - China plans to release a new version of the national reimbursement drug list before the end of November, and multinational companies will likely see lower prices due to a new price negotiation system